Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major

被引:89
作者
Coelho, AC
Beverley, SM
Cotrim, PC
机构
[1] Univ Sao Paulo, Sch Med, Inst Trop Med, BR-05403900 Sao Paulo, Brazil
[2] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
关键词
Leishmania major; pentamidine; drug resistance; gene transfection; overexpression; P-glycoprotein;
D O I
10.1016/S0166-6851(03)00162-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pentamidine (PEN) is a second-line agent in the treatment of leishmaniasis whose mode of action and resistance is not well understood. Here, we used a genetic strategy to search for loci able to mediate PEN resistance (PENr) when overexpressed in Leishmania major. A shuttle cosmid library containing genomic DNA inserts was transfected into wild-type promastigotes and screened for PEN-resistant transfectants. Two different cosmids identifying the same locus were found, which differed from other known Leishmania drug resistance genes. The PENr gene was mapped by deletion and transposon mutagenesis to an open reading frame (ORF) belonging to the P-glycoprotein (PGP)/MRP ATP-binding cassette (ABC) transporter superfamily that we named pentamidine resistance protein 1 (PRP1). The predicted PRP1 protein encodes 1807 amino acids with the typical dimeric structure involving 10 transmembrane domains and two nucleotide-binding domains (NBDs). PRP1-mediated PENr could be reversed by verapamil and PRP1 overexpressors showed cross-resistance to trivalent antimony but not to pentavalent antimony (glucantime). Although the degree of PENr was modest (1.7- to 3.7-fold), this may be significant in clinical drug resistance given the marginal efficacy of PEN against Leishmania. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 38 条
[31]  
Pérez-Guillé G, 2001, J PHARM PHARM SCI, V4, P159
[32]   IN-VITRO ANTILEISHMANIAL PROPERTIES OF TRIVALENT AND PENTAVALENT ANTIMONIAL PREPARATIONS [J].
ROBERTS, WL ;
BERMAN, JD ;
RAINEY, PM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1234-1239
[33]   SHUTTLE COSMID VECTORS FOR THE TRYPANOSOMATID PARASITE LEISHMANIA [J].
RYAN, KA ;
DASGUPTA, S ;
BEVERLEY, SM .
GENE, 1993, 131 (01) :145-150
[34]  
Sambrook J., 2002, MOL CLONING LAB MANU
[35]  
SANDS M, 1985, REV INFECT DIS, V7, P625
[36]   LEISHMANIA GENE AMPLIFICATION - A MECHANISM OF DRUG-RESISTANCE [J].
SEGOVIA, M .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1994, 88 (02) :123-130
[37]   Gene amplification in amphotericin B-resistant Leishmania tarentolae [J].
Singh, AK ;
Papadopoulou, B ;
Ouellette, M .
EXPERIMENTAL PARASITOLOGY, 2001, 99 (03) :141-147
[38]   cis and trans factors affecting Mos1 mariner evolution and transposition in vitro, and its potential for functional genomics [J].
Tosi, LRO ;
Beverley, SM .
NUCLEIC ACIDS RESEARCH, 2000, 28 (03) :784-790